Performance analysis of Oaktree Acquisition Corp III Life Sciences - Units (1 Ordinary Cls A & 1/5 Warr) (OACCU)
Annual Return
Since Oct 24, 2024, OACCU has had an average annual return of +4.48%, underperforming the benchmark SPY, which returned +19.13% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.19% | +5.73% | +1.30% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.84% | -1.11% | +0% | +0% | +2.90% | -2.37% | +0.19% | ||||||
| 2025 | +0.49% | -0.59% | +3.16% | +0.10% | +1.05% | +0.47% | +0% | -0.38% | +0.76% | +0.19% | +2.62% | -2.19% | +5.73% |
| 2024 | +0% | +1% | +0.30% | +1.30% |
Drawdown analysis of Oaktree Acquisition Corp III Life Sciences - Units (1 Ordinary Cls A & 1/5 Warr) (OACCU)
The maximum drawdown for the OACCU was -4.45%, occurring on Sep 3, 2025. Recovery took 28 trading sessions.
The current OACCU drawdown is -2.98%.
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -4.45% | Jul 23, 2025 | 29 | Sep 3, 2025 | 28 | Oct 13, 2025 | 57 |
| -3.91% | May 22, 2025 | 2 | May 27, 2025 | 39 | Jul 23, 2025 | 41 |
| -3.80% | Oct 13, 2025 | 15 | Nov 3, 2025 | Ongoing | Ongoing | Ongoing |
| -1.57% | Nov 22, 2024 | 3 | Nov 27, 2024 | 67 | Mar 10, 2025 | 70 |
| -1.34% | Mar 31, 2025 | 1 | Apr 1, 2025 | 18 | Apr 28, 2025 | 19 |
| -1.07% | Mar 10, 2025 | 5 | Mar 17, 2025 | 1 | Mar 18, 2025 | 6 |
| -0.89% | Nov 1, 2024 | 6 | Nov 11, 2024 | 9 | Nov 22, 2024 | 15 |
| -0.58% | Mar 18, 2025 | 2 | Mar 20, 2025 | 3 | Mar 25, 2025 | 5 |
| -0.10% | Oct 29, 2024 | 1 | Oct 30, 2024 | 2 | Nov 1, 2024 | 3 |